Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aminophylline 105mg/5ml oral liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing diprophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parenteral dyphylline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dyphylline+guaifenesin 100mg/100mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 100mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Siltussin sa 100mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 1200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 300mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 600mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ephedrine sulfate 25 milligram and guaifenesin 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cetylpyridinium and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing choline theophyllinate and guaifenesin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ephedrine and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diprophylline- and guaifenesin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ephedrine sulfate and hydroxyzine hydrochloride and theophylline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing masoprocol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing choline theophyllinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing guaifenesin and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline hydrate 350mg modified-release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline hydrate 225mg modified-release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aminophylline hydrate 100mg modified-release tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Drug groups primarily affecting the musculoskeletal system allergy |
Causative agent (attribute) |
False |
agent de l'appareil locomoteur |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |